Medicare Drug Benefit
SB 503 by Sen. Liz Figueroa (D-Fremont) was amended to eliminate all provisions related to the Medicare drug benefit. The bill would have authorized DHS to reimburse pharmacies for Medicare prescription drug plan copayments for customers who are dually eligible for Medicare and Medi-Cal. SB 503 now addresses peer review requirements for the Board of Accountancy (Bill text, 8/8).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.